Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Baker

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|December 30, 2015
Low-dose morphine for moderate cancer painHolly Baker
The Lancet. Oncology|May 11, 2016
Surveillance benefit for pancreatic cancer in high-risk individualsHolly Baker
The Lancet. Gastroenterology & Hepatology|March 15, 2025
Research in BriefHolly Baker
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Research in BriefHolly Baker
The Lancet. Oncology|October 21, 2015
21-gene assay identifies patients who can avoid chemotherapyHolly Baker
The Lancet. Oncology|August 18, 2015
Docetaxel for hormone-sensitive metastatic prostate cancerHolly Baker
The Lancet. Oncology|August 25, 2015
High HLA-DP expression and graft-versus-host diseaseHolly Baker
The Lancet. Oncology|September 6, 2017
Discontinuation of melanoma combination immunotherapyHolly Baker
The Lancet. Oncology|October 17, 2017
First-line obinutuzumab for follicular lymphomaHolly Baker
The Lancet. Oncology|September 1, 2015
E-cigarettes and subsequent tobacco use in adolescenceHolly Baker
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|December 30, 2015
Low-dose morphine for moderate cancer painHolly Baker
The Lancet. Oncology|May 11, 2016
Surveillance benefit for pancreatic cancer in high-risk individualsHolly Baker
The Lancet. Gastroenterology & Hepatology|March 15, 2025
Research in BriefHolly Baker
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Research in BriefHolly Baker
The Lancet. Oncology|October 21, 2015
21-gene assay identifies patients who can avoid chemotherapyHolly Baker
The Lancet. Oncology|August 18, 2015
Docetaxel for hormone-sensitive metastatic prostate cancerHolly Baker
The Lancet. Oncology|August 25, 2015
High HLA-DP expression and graft-versus-host diseaseHolly Baker
The Lancet. Oncology|September 6, 2017
Discontinuation of melanoma combination immunotherapyHolly Baker
The Lancet. Oncology|October 17, 2017
First-line obinutuzumab for follicular lymphomaHolly Baker
The Lancet. Oncology|September 1, 2015
E-cigarettes and subsequent tobacco use in adolescenceHolly Baker
Pageof 8